San Francisco 49ers, fullback Kyle Juszczyk agree to five-year, $27 million contract, per report
With each passing NFL offseason, the debate concerning the value of running backs on the open market becomes louder and louder.
But the fullback market was all the rage Sunday night.
According to NFL Network, the San Francisco 49ers and Kyle Juszczyk agreed to a five-year, $27 million deal. It's a slight raise for one of the league's best fullbacks, as the four-year, $21 million contract he signed in 2017 had expired after last season.
Juszczyk, who will turn 30 next month, had already been the highest-paid fullback in the game, per Over The Cap. The $5.4 million average annual value is a slight raise from the $5.25 million AAV on the prior deal.
Juszczyk began his career with the Baltimore Ravens and made the Pro Bowl during his final season with the team in 2016. He's been selected to the game in each of his four seasons with the 49ers.
Sika To Acquire Supermassa Do Brasil – Quick Facts
Sika (SXYAY.PK,SKFOF.PK) has agreed to acquire Supermassa do Brasil Ltda, a mortar manufacturer in Brazil. It operates under the brand BR Massa in the Brazilian market. The company holds a key market position in the region of Minas Gerais, mainly offering tile setting materials and facade mortars.
Sika said the acquisition complements the production footprint with a mortar manufacturing facility in a region where the company has not previously had its own plant.
Christoph Ganz, Regional Manager Americas, said: “With BR Massa we will be able to better serve and supply our customers in the Minas Gerais region. The enhanced access to the distribution channel, supported by the expanded local supply chain, will contribute to the continued penetration of the Brazilian market.”
China has administered 64.98 million COVID-19 vaccine doses as of March 14: official
BEIJING (Reuters) – China has administered 64.98 million doses of COVID-19 vaccines as of March 14, Li Bin, an official with China’s National Health Commission, said during a news conference.
Roche To Buy GenMark Diagnostics In $1.8 Bln Cash Deal – Quick Facts
Swiss drug major Roche Group (RHHBY) announced Monday its agreement to acquire GenMark Diagnostics (GNMK) for $24.05 per share in an all-cash transaction. The total transaction value would be around $1.8 billion on a fully diluted basis.
The deal price represents a premium of approximately 43% to GenMark’s unaffected closing share price on February 10, the last trading day before a media report was published speculating about a potential sale process.
Under the deal terms, Roche will promptly commence a tender offer to buy all of GenMark’s common stock. Following the completion of the tender offer, Roche will acquire all remaining shares at $24.05 per share in cash through a second step merger.
The boards of directors of both GenMark and Roche unanimously approved the merger agreement.
The transaction is expected to close in the 2nd quarter of 2021 and is subject to customary closing conditions.
Following the deal closure, GenMark’s principal operations will continue at its current location in Carlsbad, California.
Roche expects GenMark’s syndromic panel testing portfolio to complement its current molecular diagnostics portfolio and the Roche global network will enable expanded reach for GenMark’s products.
In the deal, Citi is acting as financial advisor to Roche, and J.P. Morgan Securities LLC is acting as exclusive financial advisor to GenMark.
What the Grammys got right and wrong about diversity, from Beyoncé to BTS
The 2021 Grammy Awards were always going to be a little awkward, given pandemic constraints. But the show managed to soldier on anyway – and indicated it’s been paying attention to criticism about diversity and inclusion by recognizing Black and female artists with wins in major categories.
The Recording Academy – the voting body behind the Grammy Awards – has been working to diversify its membership and organization, accelerating efforts over the last year. Viewers will be pleased that the academy seems to be making good on those efforts for now – except when it came to record of the year.
At Sunday night’s ceremony, the slate of winners reflected current music tastes and sales charts by honoring artists like Beyoncé, Megan Thee Stallion, Dua Lipa and Taylor Swift. Here’s a closer look at what they got right – and wrong.
The full winners list: Beyoncé makes history with most wins, Billie Eilish wins second record of the year
ARYZTA Posts H1 Underlying Loss From Cont. Ops. – Quick Facts
ARYZTA AG (ARZTY.PK,ARZTF.PK) reported a first half IFRS loss from continuing operations of 48.8 million euros compared to a loss of 334.7 million euros, previous year. IFRS loss per share, in cent, from continuing operations was 7.2 compared to a loss of 36.0. Underlying EBITDA declined 36.1% to 76.1 million euros. Underlying net loss from continuing operations was 30.8 million euros compared to profit of 25.7 million euros. Underlying loss per share from continuing operations, in cent, was 3.1 compared to profit of 2.6.
First half Group revenue from continuing operations was 752.5 million euros, a decline of 21.0% from prior year.